Anandamide content is increased and CB 1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia

Neuroscience

Volumn 129, Issue 3, 2004, Pages 743-750

  Muthian, S ^a,b   Rademacher, D J ^a   Roelke, C T ^a   Gross, G J ^a   Hillard, C J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b PFIZER INC   (United States)

Author keywords

2 arachidonoylglycerol; anandamide; endocannabinoid; middle cerebral artery occlusion; N arachidonoylethanolamine; SR141716

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; AMINE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ARACHIDONIC ACIDS; BENZOFURANS; BLOOD PRESSURE; BRAIN CHEMISTRY; BRAIN INFARCTION; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MASS SPECTROMETRY; MORPHOLINES; NAPHTHALENES; NEUROLOGIC EXAMINATION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REPERFUSION INJURY; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 8444250235     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.08.044     Document Type: Article

References (50)

1. J.B. Bederson, L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis, H. Bartkowski Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17 1986 472 476
2. E.V. Berdyshev, P.C. Schmid, R.J. Krebsbach, C.J. Hillard, C. Huang, N. Chen, Z. Dong, H.H.O. Schmid Cannabinoid receptor independent cell signaling by N-acylethanolamines Biochem J 260 2001 67 75
3. C. Berger, P.C. Schmid, W.R. Schabitz, M. Wolf, S. Schwab, H.H.O. Schmid Massive accumulation of N-acylethanolamines after stroke: cell signaling in acute cerebral ischemia? J Neurochem 88 2004 1159 1167
4. G.C. Chan, T.R. Hinds, S. Impey, D.R. Storm Hippocampal neurotoxicity of delta9-tetrahydrocannabinol J Neurosci 18 1998 5322 5332
5. A.B. Clement, E.G. Hawkins, A.H. Lichtman, B.F. Cravatt Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase J Neurosci 23 2003 3916 3923
6. M. De Ryck, J. Van Reempts, M. Borgers, A. Wauquier, P.A. Janssen Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats Stroke 20 1989 1383 1390
7. W.L. Dewey Cannabinoid pharmacology Pharmacol Rev 38 1986 151 178
8. 1 receptor Neuroreport 12 2001 3973 3978
9. P.J. Eames, M.J. Blake, S.L. Dawson, R.B. Panerai, J.F. Potter Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke J Neurol Neurosurg Psychiatry 72 2002 467 472
10. 1 receptor to stimulation of cAMP accumulation J Pharmacol Exp Ther 284 1998 291 297
11. M.A. Foulkes, P.A. Wolf, T.R. Price, J.P. Mohr, D.B. Hier The Stroke Data Bank: design, methods, and baseline characteristics Stroke 19 1988 547 554
12. A. Franklin, S. Parmentier-Batteur, L. Walter, D.A. Greenberg, N. Stella Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility J Neurosci 23 2003 7767 7775
13. T.F. Freund, I. Katona, D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 2003 1017 1066
14. 2+ channel current Am J Physiol 276 1999 H2085 2093
15. H.H. Hansen, C. Ikonomidou, P. Bittigau, S.H. Hansen, H.S. Hansen Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death J Neurochem 76 2001 39 46
16. H.H. Hansen, I. Azcoitia, S. Pons, J. Romero, L.M. Garcia-Segura, J.A. Ramos, H.S. Hansen, J. Fernandez-Ruiz Blockade of cannabinoid CB(1) receptorfunction protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity J Neurochem 82 2002 154 158
17. H.H. Hansen, P.C. Schmid, P. Bittigau, I. Lastres-Becker, F. Berrendero, J. Manzanares, C. Ikonomidou, H.H. Schmid, J.J. Fernandez-Ruiz, H.S. Hansen Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration J Neurochem 78 2001 1415 1427
18. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. DeCosta, K.C. Rice Cannabinoid receptor localization in brain Proc Natl Acad Sci USA 87 1990 1932 1936
19. K. Isayama, L.H. Pitts, M.C. Nishimura Evaluation of 2,3,5- triphenyltetrazolium chloride staining to delineate rat brain infarcts Stroke 22 1991 1394 1398
20. 1-like cannabinoid receptors J Pharmacol Exp Ther 281 1997 1030 1037
21. P.W. Landfield, L.B. Cadwallader, S. Vinsant Quantitative changes in hippocampal structure following long-term exposure to delta 9tetrahydrocannabinol: possible mediation by glucocorticoid systems Brain Res 443 1988 47 62
22. E.Z. Longa, P.R. Weinstein, S. Carlson, R. Cummins Reversible middle cerebral artery occlusion without craniotomy in rats Stroke 20 1989 84 91
23. D.G. MacGregor, H.V. Carswell, D.I. Graham, J. McCulloch, I.M. Macrae Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat Eur J Neurosci 12 2000 58 66
24. 1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
25. R. Mathew, W. Wilson, D. Humphreys, J. Lowe, K. Wiethe Changes in middle cerebral artery velocity after marijuana Biol Psychiatry 32 1992 164 169
26. R.J. Mathew, W.H. Wilson, R. Davis Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics Pharmacol Biochem Behav 75 2003 309 318
27. R.J. Mathew, W.H. Wilson, D.F. Humphreys, J.V. Lowe, K.E. Wiethe Regional cerebral blood flow after marijuana smoking J Cereb Blood Flow Metab 12 1992 750 758
28. F. Mauler, J. Mittendorf, E. Horvath, J. De Vry Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4- trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties J Pharmacol Exp Ther 302 2002 359 368
29. F. Mauler, V. Hinz, K.H. Augstein, M. Fassbender, E. Horvath Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271 Brain Res 989 2003 99 111
30. R. Mechoulam, A.H. Lichtman Neuroscience: stout guards of the central nervous system Science 302 2003 65 67
31. R. Mechoulam, D. Panikashvili, E. Shohami Cannabinoids and brain injury: therapeutic implications Trends Mol Med 8 2002 58 61
32. T. Nagayama, A.D. Sinor, R.P. Simon, J. Chen, S.H. Graham, K. Jin, D.A. Greenberg Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 1999 2987 2995
33. V. Novak, A. Chowdhary, B. Farrar, H. Nagaraja, J. Braun, R. Kanard, P. Novak, A. Slivka Altered cerebral vasoregulation in hypertension and stroke Neurology 60 2003 1657 1663
34. D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanus, A. Breuer, R. Mechoulam, E. Shohami An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531
35. S. Patel, E.R. Wohlfeil, D.J. Rademacher, E.J. Carrier, L.J. Perry, A. Kundu, J.R. Falck, K. Nithipatikom, W.B. Campbell, C.J. Hillard The general anesthetic propofol increases brain N-arachidonoylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase Br J Pharmacol 139 2003 1005 1013
36. O.B. Paulson, S. Strandgaard, L. Edvinsson Cerebral autoregulation Cerebrovasc Brain Metab Rev 2 1990 161 192
37. G. Pryce, G. Giovannoni, D. Baker Mifepristone or inhibition of 11betahydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice Neurosci Lett 341 2003 164 166
38. G. Pryce, Z. Ahmed, D.J. Hankey, S.J. Jackson, J.L. Croxford, J.M. Pocock, C. Ledent, A. Petzold, A.J. Thompson, G. Giovannoni, M.L. Cuzner, D. Baker Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Brain 126 2003 2191 2202
39. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinex, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie, J.C. Breliere, G. LeFur SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 1994 240 244
40. A.C. Scallet Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals Pharmacol Biochem Behav 40 1991 671 676
41. P.C. Schmid, R.J. Krebsbach, S.R. Perry, T.M. Dettmer, J.L. Maasson, H.H. Schmid Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain FEBS Lett 375 1995 143 147
42. M. Shen, S.A. Thayer Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity Mol Pharmacol 54 1998 459 462
43. N. Stella, P. Schweitzer, D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
44. E. Sulcova, R. Mechoulam, E. Fride Biphasic effects of anandamide Pharmacol Biochem Behav 59 1998 347 352
45. T. Sugiura, N. Yoshinaga, S. Kondo, K. Waku, Y. Ishima Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain Biochem Biophys Res Commun 271 2000 654 658
46. R.A. Swanson, M.T. Morton, G. Tsao-Wu, R.A. Savalos, C. Davidson, F.R. Sharp A semiautomated method for measuring brain infarct volume J Cereb Blood Flow Metab 10 1990 290 293
47. E.T. Tzavara, M. Wade, G.G. Nomikos Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action J Neurosci 23 2003 9374 9384
48. M. van der Stelt, W.B. Veldhuis, P.R. Bar, G.A. Veldink, J.F. Vliegenthart, K. Nicolay Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity J Neurosci 21 2001 6475 6479
49. M. van der Stelt, W.B. Veldhuis, G.W. van Haaften, F. Fezza, T. Bisogno, P.R. Bar, G.A. Veldink, J.F. Vliegenthart, V. Di Marzo, K. Nicolay Exogenous anandamide protects rat brain against acute neuronal injury in vivo J Neurosci 21 2001 8765 8771
50. J.A. Wagner, Z. Jarai, S. Batkai, G. Kunos Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors Eur J Pharmacol 423 2001 203 210